This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human TACE/ADAM17 DuoSet ELISA
catalog :
DY930
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 9
Reference
Rogmans C, Kuhlmann J, Hugendieck G, Link T, Arnold N, Weimer J, et al. ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer. Cancers (Basel). 2021;13: pubmed publisher
Mendoza R, Saha N, Momeni A, Gabutan E, Alawad M, Dehghani A, et al. Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19. Heliyon. 2021;7:e07200 pubmed publisher
Yoneyama T, Gorry M, Sobo Vujanovic A, Lin Y, Vujanovic L, Gaither Davis A, et al. ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker. J Cancer. 2018;9:2559-2570 pubmed publisher
Nishide M, Nojima S, Ito D, Takamatsu H, Koyama S, Kang S, et al. Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. Ann Rheum Dis. 2017;76:1440-1448 pubmed publisher
Ortiz Pérez J, Riera M, Bosch X, De Caralt T, Perea R, Pascual J, et al. Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. PLoS ONE. 2013;8:e61695 pubmed publisher
Mamessier E, Sylvain A, Thibult M, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011;121:3609-22 pubmed publisher
Pitteri S, Jebailey L, Faca V, Thorpe J, Silva M, Ireton R, et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE. 2009;4:e7916 pubmed publisher
Li X, Magenheimer B, Xia S, Johnson T, Wallace D, Calvet J, et al. A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med. 2008;14:863-8 pubmed publisher
Bostanci N, Emingil G, Afacan B, Han B, Ilgenli T, Atilla G, et al. Tumor necrosis factor-alpha-converting enzyme (TACE) levels in periodontal diseases. J Dent Res. 2008;87:273-7 pubmed
product information
master code :
DY930
SKU :
DY930
product name :
Human TACE/ADAM17 DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human TACE/ADAM17 DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human TACE/ADAM17.
target :
TACE/ADAM17
category :
ELISAs
species :
Human
gene symbol :
ADAM17
kit type :
Solid Phase Sandwich ELISA
elisaRange :
156.00 - 10000 pg/mL
top caption :
Human TACE/ ADAM17 ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
ADAM 17, ADAM metallopeptidase domain 17, ADAM metallopeptidase domain 18, ADAM17, ADAM18, CD156b, CD156b antigen, CSVP, disintegrin and metalloproteinase domain-containing protein 17, EC 3.4.24.86, MGC71942, Snake venom-like protease, TACEcSVP, TNF-alpha convertase, TNF-alpha converting enzyme, TNF-alpha-converting enzyme, tumor necrosis factor, alpha, converting enzyme
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.